SPAC deal folds for Seattle biotech startup, months after IPO withdrawal by Charlotte Schubert on December 7, 2022December 7, 2022 at 10:49 am A deal to take Seattle biotech company Intrinsic Medicine public via a SPAC merger has fallen apart. The SPAC deal, announced in October, would have taken the startup public via… Read More